Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention

被引:19
作者
Zhou, You [1 ]
Chen, Zhangwei [1 ]
Ma, Jiaqi [1 ]
Chen, Ao [1 ]
Lu, Danbo [1 ]
Wu, Yuan [1 ]
Ren, Daoyuan [1 ]
Zhang, Chi [1 ]
Dai, Chunfeng [1 ]
Zhang, Yaqi [1 ]
Qian, Juying [1 ]
Ge, Junbo [1 ]
机构
[1] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Dept Cardiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Periprocedural myocardial injury; Percutaneous coronary intervention; Cardiac troponin T; CREATINE KINASE-MB; CARDIAC TROPONIN-T; PROGNOSTIC VALUE; MICROEMBOLIZATION; INFARCTION; MYONECROSIS; ELEVATION; DIAGNOSIS; IMPACT; DAMAGE;
D O I
10.1016/j.jjcc.2020.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although technological and equipment innovations have given rise to delicate and safe coronary intervention procedures, periprocedural myocardial injury (PMI) is still one of the common complications. The relationship between PMI, defined by various biomarker thresholds, and clinical prognosis remains controversial. We sought to assess the determinants and prognosis of PMI in patients with stable coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI). Methods: Consecutive stable CAD patients with negative preoperative troponin T levels undergoing elective PCI in our hospital were enrolled from July 2017 to December 2017. PMI was defined as troponin T values >99th percentile upper reference limit (URL) within 16-24 h post-PCI. The correlation of cardiovascular events and PMI was assessed after a median follow-up of 18 months. Results: PMI occurred in 45.3% of the 1572 patients included, with 11.2% having troponin T levels elevated more than 5 times the URL after PCI. Independent risk factors for PMI were age >= 65 years, prior PCI, bifurcation lesion, stent number, and multivessel disease. During the follow-up period, patients with PMI had a higher incidence of unplanned revascularization [10.8% vs. 7.2%, adjusted hazard ratio (adHR) 1.40, 95% confidence interval (CI) 1.04-2.06; p = 0.045] and target vessel revascularization (5.8% vs. 2.7%, adHR 1.90, 95% CI 1.06-3.38; p = 0.030) than those without PMI. However, no significant impact of PMI on the risk of death and myocardial infarction was found. Conclusions: PMI defined by troponin T levels >99th percentile URL correlated with an increased risk of cardiovascular events in stable CAD patients undergoing elective PCI. (C) 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [21] Periprocedural myocardial injury after elective percutaneous coronary intervention in stable angina pectoris: a tertiary center experience
    Sarilar, Mert
    Oktay, Veysel
    Demirci, Gursu
    Oksen, Dogac
    Sansoy, Vedat
    COR ET VASA, 2023, 65 (03) : 508 - 513
  • [22] Incidence and Prognostic Significance of Myocardial Injury after Elective Percutaneous Coronary Intervention in Duhok, Iraq
    Mohammad, Ameen M.
    Guelker, Hartmut K.
    Sheikhow, Sabri K.
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2021, 7 (05): : 290 - 294
  • [23] Identification of patients at higher risk for myocardial injury following elective coronary artery intervention
    Abu Sharar, Haitham
    Helfert, Stefanie
    Vafaie, Mehrshad
    Pleger, Sven T.
    Chorianopoulos, Emmanuel
    Bekeredjian, Raffi
    Katus, Hugo A.
    Giannitsis, Evangelos
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (03) : 578 - 585
  • [24] The Effect of High Dose Cilostazol and Rosuvastatin on Periprocedural Myocardial Injury in Patients with Elective Percutaneous Coronary Intervention
    Ari, H.
    Emlek, N.
    Ari, S.
    Cosar, S.
    Doganay, K.
    Aydin, C.
    Tenekecioglu, E.
    Tutuncu, A.
    Yontar, O. C.
    Gurdogan, M.
    Bozat, T.
    Melek, M.
    ACTA CARDIOLOGICA SINICA, 2015, 31 (04) : 292 - 300
  • [25] Impact of coronary plaque characteristics on periprocedural myocardial injury in elective percutaneous coronary intervention
    Kyohei Usami
    Hiroaki Watabe
    Tomoya Hoshi
    Shunsuke Sakai
    Daigo Hiraya
    Akira Sato
    Masaki Ieda
    European Radiology, 2023, 33 : 3020 - 3028
  • [26] Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention
    Vatankulu, Mehmet Akif
    Murat, Sani Namik
    Demircelik, Bora
    Turfan, Murat
    Sonmez, Osman
    Duran, Mustafa
    Bacaksiz, Ahmet
    Ornek, Ender
    Tasal, Abdurrahman
    Goktekin, Omer
    RENAL FAILURE, 2013, 35 (07) : 931 - 935
  • [27] Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study
    Chen, Zhang-Wei
    Yang, Hong-Bo
    Chen, Ying-Hua
    Ma, Jian-Ying
    Qian, Ju-Ying
    Ge, Jun-Bo
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [28] Relationship of non-cardiac biomarkers with periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
    Zeng, Rui-Xiang
    Li, Jian-Jun
    Liao, Peng-da
    Zhang, Min-Zhou
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 : 726 - 733
  • [29] Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention
    Harada, Kazuhiro
    Kikuchi, Ryosuke
    Suzuki, Susumu
    Tanaka, Akihito
    Aoki, Toshijiro
    Iwakawa, Naoki
    Kojima, Hiroki
    Hirayama, Kenshi
    Mitsuda, Takayuki
    Sumi, Takuya
    Negishi, Yosuke
    Ishii, Hideki
    Murohara, Toyoaki
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [30] Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention?
    Tomaniak, Mariusz
    Koltowski, Lukasz
    Kochman, Janusz
    Huczek, Zenon
    Rdzanek, Adam
    Pietrasik, Arkadiusz
    Gasecka, Aleksandra
    Gajda, Sylwia
    Opolski, Grzegorz
    Filipiak, Krzysztof J.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (11): : 730 - 740